These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18320951)

  • 21. B-type natriuretic peptide in heart failure.
    Hassan Y; Shapira AR; Hassan S
    N Engl J Med; 2002 Dec; 347(24):1976-8; author reply 1976-8. PubMed ID: 12479192
    [No Abstract]   [Full Text] [Related]  

  • 22. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 25. B-type natriuretic peptides: prognostic markers in stable coronary artery disease.
    Omland T
    Expert Rev Mol Diagn; 2008 Mar; 8(2):217-25. PubMed ID: 18366308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of heart failure.
    Chang AM; Maisel AS; Hollander JE
    Heart Fail Clin; 2009 Jan; 5(1):25-35, vi. PubMed ID: 19026383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heart failure--yes or no? The third heart sound and markers point the way].
    Silber S
    MMW Fortschr Med; 2004 Sep; 146(37):29. PubMed ID: 15887698
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart failure and B-type natriuretic protein.
    Hoyne J
    Clin Lab Sci; 2009; 22(4):233-9. PubMed ID: 19967919
    [No Abstract]   [Full Text] [Related]  

  • 29. Serial measurements of plasma B-type natriuretic peptides: what do they tell us?
    Richards AM
    J Am Coll Cardiol; 2008 Sep; 52(12):1004-5. PubMed ID: 18786481
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 31. [The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology].
    van Lieshout J; Rutten FH; Walma EP; Wiersma TJ; Goudswaard AN
    Ned Tijdschr Geneeskd; 2006 Apr; 150(14):818-9. PubMed ID: 16649404
    [No Abstract]   [Full Text] [Related]  

  • 32. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
    Javadzadeh J; Collén AC; Manhem K; Swedberg K
    Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
    [No Abstract]   [Full Text] [Related]  

  • 33. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation.
    Taub PR; Daniels LB; Maisel AS
    Heart Fail Clin; 2009 Apr; 5(2):169-75. PubMed ID: 19249686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea.
    Mueller C
    ACP J Club; 2005; 142(1):A14-5; author reply A15. PubMed ID: 15690582
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea.
    Schwam E
    ACP J Club; 2005; 142(1):A14; author reply A15. PubMed ID: 15656541
    [No Abstract]   [Full Text] [Related]  

  • 38. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 40. Learning to use a biomarker. More about B-type natriuretic peptide.
    Mills RM
    J Am Coll Cardiol; 2008 Jun; 51(24):2336-8. PubMed ID: 18549919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.